Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, David Stejskal, Zhiguang Zhou, Feng Liu, Rachel L.C. Wong, Wing‐Sun Chow, Annette W.K. Tso, Karen S.L. Lam, Aimin Xu
Format: Artigo
Jezik:angleščina
Izdano: 2008
Online dostop:https://doi.org/10.2337/db07-1476
Oznake: Označite
Brez oznak, prvi označite!